McKesson to Acquire US Oncology
Ropes & Gray is representing US Oncology in a proposed acquisition by McKesson Corp. worth $2.16 billion including debt, announced November 1. McKesson Corp., the largest U.S. drug distributor, plans to buy US Oncology to expand its offerings to cancer patients. US Oncology is owned by private equity firm Welsh Carson Anderson & Stowe.
The Ropes & Gray team was led by New York-based partner Othon Prounis.